Next Article in Journal
Synergistic Activity of Tetrandrine and Colistin against mcr-1-Harboring Escherichia coli
Next Article in Special Issue
Comparison of Patient-Reported Outcomes Measures and Quality-Adjusted Life Years Following One- and Two-Stage Septic Knee Exchange
Previous Article in Journal
Antimicrobial Resistance Pattern, Clustering Mechanisms and Correlation Matrix of Drug-Resistant Escherichia coli in Black Bengal Goats in West Bengal, India
Previous Article in Special Issue
Intraosseous Regional Administration of Prophylactic Antibiotics in Total Knee Arthroplasty
 
 
Article
Peer-Review Record

The Impact of Patient-Reported Penicillin or Cephalosporin Allergy on the Occurrence of the Periprosthetic Joint Infection in Primary Knee and Hip Arthroplasty

Antibiotics 2022, 11(10), 1345; https://doi.org/10.3390/antibiotics11101345
by Stella Stevoska 1,2,*, Verena Behm-Ferstl 1,2, Stephanie Zott 1,2, Christian Stadler 1,2, Sophie Schieder 1,2, Matthias Luger 1,2, Tobias Gotterbarm 1,2 and Antonio Klasan 2,3
Reviewer 1:
Antibiotics 2022, 11(10), 1345; https://doi.org/10.3390/antibiotics11101345
Submission received: 5 September 2022 / Revised: 23 September 2022 / Accepted: 29 September 2022 / Published: 2 October 2022
(This article belongs to the Special Issue Antibiotics Prophylaxis for Knee Arthroplasty: Benefits and Problems)

Round 1

Reviewer 1 Report

This is a retrospective clinical study, the principal aim was to identify and compare the occurrence of PJI in patients who received cefuroxime as a prophylactic antibiotic before primary arthroplasty with patients who due to reported allergies received a non-cefuroxime (generally clyndamicin) as prophylactic antibiotic.

The results with figures and tables are clearly presented.

The main considerations that must be made before considering the article for publication are:

The definition of PJI that they use: Cases in which an organism has been identified were considered to meet the consensus criteria for PJI, does not conform to the established standards. The Parvisi study to which they refer or the IDSA guidelines establish that for a higher criterion, 2 positive cultures for the same microorganism are necessary. We believe that the PJI criteria used should be better specified, showing, if possible, how many patients had major criteria. The number of patients included in the non-cephalosporin antibiotic prophylaxis arm is probably insufficient to demonstrate differences. Due to the small number of patients, they cannot adjust for the differences observed between the study arms: gender, ASA.

As less important consideration: 

I think the abbreviations used in the article should be specified.

It would be important to show the results of the microbiological isolations in a table to see if there are differences in the isolated microorganisms according to the prophylactic treatment administered.

They use as prophylaxis, in patients with allergy clindamycin, an antibiotic rarely used in surgical prophylaxis. It is important not to extrapolate it to other antibiotics, this should be stated in the discussion.

 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

      Good Introduction, results , discussion and conclusion of impact of patient reported cephalosporin or penicillin allergy on occurrence of periprosthetic joint infection. Good (non-inferiority) conclusions drawn in an area not researched before.

 

The research’s main question is the impact of patient-reported penicillin or cephalosporin al- 2 lergy on the occurrence of the periprosthetic joint infection in 3 primary knee and hip arthroplasty.

The manuscript is an important area of antibiotic prophylaxis that has not been extensively studied.

I think conclusions drawn are appropriate and references are appropriate and extensive.   I would place Methods section after introduction and before results and discussion. Besides, I have no other additional comments.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop